Kinins contribute to the improvement of insulin sensitivity during treatment with angiotensin converting enzyme inhibitor.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  HYPERTENSION

• Publication date

  1994-04-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1161/01.HYP.23.4.450PMID 8144214
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of chronic angiotensin converting enzyme inhibition on glucose tolerance and insulin sensitivity in essential hypertension.

  1992cited by this paper
• Chronic kinin receptor blockade attenuates the antihypertensive effect of ramipril.

  1992cited by this paper
• Effect of Antihypertensive Drugs on Insulin, Glucose, and Lipid Metabolism

  1991cited by this paper
• Glucose Tolerance and Insulin Action in Rats With Renovascular Hypertension

  1991cited by this paper
• The hemodynamic link between insulin resistance and hypertension.

  1991cited by this paper
• Insulin resistance--mechanisms, syndromes, and implications.

  1991cited by this paper
• Metabolic Effects of Kinins: Historical and Recent Developments

  1990cited by this paper
• Insulin resistance in essential hypertension.

  1990cited by this paper
• The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension.

  1989cited by this paper
• Circulating versus local renin‐angiotensin system in cardiovascular homeostasis

  1988cited by this paper
• Insulin resistance in essential hypertension.

  1987cited by this paper
• In vivo glucose metabolism in the awake rat: tracer and insulin clamp studies.

  1987cited by this paper
• Glucose clamp technique: a method for quantifying insulin secretion and resistance.

  1979cited by this paper

• Data-driven cluster analysis and external validation identify phenotypic subgroups in renin-independent aldosteronism with differential cardiovascular risk and therapeutic implications

  2025cites this paper
• Current Approaches to Treatment and Protein Intake Management in Pre-Dialysis Chronic Kidney Disease: Impact on Physical Exercise

  2024influential citation
• Lower Incidence of Hypoglycemia With Angiotensin Receptor Blocker Versus ACE Inhibitor Therapy in People With or Without Diabetes.

  2024cites this paper
• Diabetes leading to heart failure and heart failure leading to diabetes: epidemiological and clinical evidence

  2022cites this paper
• An Overview of Clinically Imperative and Pharmacodynamically Significant Drug Interactions of Renin-Angiotensin-Aldosterone System (RAAS) Blockers

  2022cites this paper
• Secondary Metabolites of Plants as Modulators of Endothelium Functions

  2021cites this paper
• Effect of carvedilol versus nebivolol on insulin resistance among non-diabetic, non-ischemic cardiomyopathy with heart failure

  2020cites this paper
• Bradykinin B2 Receptor Signaling Increases Glucose Uptake and Oxidation: Evidence and Open Questions

  2020influential citation
• Role of renin–angiotensin–aldosterone system inhibitors in heart failure and chronic kidney disease

  2020cites this paper
• Comparative effectiveness of angiotensin receptor blockers vs. angiotensin-converting enzyme inhibitors on cardiovascular outcomes in patients initiating peritoneal dialysis

  2017cites this paper
• Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers for Prevention of Type 2 Diabetes

  2016cites this paper
• Effects of angiotensin converting enzyme inhibitor: ramipril on different biochemical parameters in essential hypertensive patients -

  2016cites this paper
• contractionsed glucose transport after muscle Role of kallikrein-kininogen system in

  2015cites this paper
• Rôle du système kallicréine-kinine(s) dans les complications du diabète

  2015cites this paper
• Possible Study of Drug-Drug Interactions between Lisinopril and Gliclazide in Experimental Animals

  2015cites this paper
• Olmesartan vs. Ramipril in Elderly Hypertensive Patients: Review of Data from Two Published Randomized, Double-Blind Studies

  2014cites this paper
• G protein-coupled receptors as regulators of glucose homeostasis and therapeutic targets for diabetes mellitus.

  2014cites this paper
• The relationship of Bradykinin B₂ receptor gene variation with obesity, hypertension and lipid variables in obese patients.

  2014cites this paper
• Valsartan, independently of AT1 receptor or PPARγ, suppresses LPS-induced macrophage activation and improves insulin resistance in cocultured adipocytes.

  2012cites this paper
• Effects of angiotensin II AT1 receptor inhibition and exercise training on insulin action in rats on high-fat diet.

  2012cites this paper
• Prevention of Type 2 Diabetes Mellitus Through Inhibition of the Renin-Angiotensin System

  2012cites this paper
• The Role of the Angiotensin System in Cardiac Glucose Homeostasis

  2012cites this paper
• Challenges in Comparing Effectiveness of Angiotensin Receptor Blockers vs. Angiotensin-Converting Enzyme Inhibitors for Hypertension in Medicare Data

  2011cites this paper
• Cardioprotective properties of bradykinin: role of the B2 receptor

  2010cites this paper
• Are Renin-Angiotensin-Aldosterone System Blockers Distinguishable Based on Cardiovascular and Renal Outcomes in Nephropathy?

  2009cites this paper
• ANGIOTENSIN RECEPTOR BLOCKERS : CURRENT LIMITATIONS AND UNMET NEEDS

  2009cites this paper
• Next generation multifunctional angiotensin receptor blockers

  2009cites this paper
• Microcirculation in hyperglycemic patients with IDDM without diabetic complications--effect of low-dose angiotensin-converting enzyme inhibition.

  2009cites this paper
• Effect of metformin on weight gain during antihypertensive treatment with a beta-blocker in Chinese patients.

  2009cites this paper
• Effect of delapril/manidipine vs olmesartan/ hydrochlorothiazide combination on insulin sensitivity and fibrinogen in obese hypertensive patients.

  2008cites this paper
• Differences between angiotensin converting enzyme inhibitors and receptor blockers

  2008cites this paper
• Angiotensin-Converting Enzyme Inhibition After Experimental Myocardial Infarct: Role of the Kinin B1 and B2 Receptors

  2008cites this paper
• Clinical investigation of the effects of pioglitazone on the improvement of insulin resistance and blood pressure in type 2-diabetic patients undergoing hemodialysis.

  2008cites this paper
• Genetically altered animals in the study of the metabolic functions of peptide hormone systems

  2008cites this paper
• THE RISK OF DEVELOPING DIABETES IN HYPERTENSION : -Insulin sensitivity, AT-1 receptor blockade and sympathetic activity

  2008cites this paper
• The effect of antihypertensive drugs and drug combinations on the incidence of new‐onset type‐2 diabetes mellitus

  2007cites this paper
• Effect of angiotensin I-converting enzyme inhibitory peptide from rice dregs protein on antihypertensive activity in spontaneously hypertensive rats.

  2007cites this paper
• Mechanisms of protective effects induced by blockade of the renin–angiotensin system: novel role of the pancreatic islet angiotensin‐generating system in Type 2 diabetes

  2007cites this paper
• Aliskiren, a Novel Oral Renin Inhibitor, Provides Dose-Dependent Efficacy and Placebo-Like Tolerability in Japanese Patients with Hypertension

  2006cites this paper
• RAS inhibition in hypertension

  2006cites this paper
• Enhancement of muscle glucose uptake by the vasopeptidase inhibitor, omapatrilat, is independent of insulin signaling and the AMP kinase pathway.

  2006cites this paper
• The antidiabetic effect of angiotensin II receptor antagonists: evidence, mechanisms and clinical significance

  2006cites this paper
• Metabolic effects of antihypertensive agents: role of sympathoadrenal and renin-angiotensin systems

  2006cites this paper
• [Intracellular signal transduction of vascular injury in insulin resistance].

  2006cites this paper
• Effects of the vasopeptidase inhibitor omapatrilat on peri- and postmyocardial infarction in Zucker lean rats.

  2005cites this paper
• EFFECTS OF LOSARTAN - GLIBENCLAMIDE COMBINATION THERAPY ON THE METABOLISM IN HYPERTENSIVE NIDDM PATIENTS

  2005cites this paper
• Production of Antihypertensive Angiotensin I-Converting Enzyme Inhibitor from Malassezia pachydermatis G-14

  2005cites this paper
• Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials.

  2005cites this paper
• Mechanism of improving effect of losartan on insulin sensitivity of non-insulin-dependent diabetes mellitus rats.

  2004cites this paper
• Insulin resistance and GLUT-4 glucose transporter in adipocytes from hypertensive rats.

  2004cites this paper
• Identification of Telmisartan as a Unique Angiotensin II: Receptor Antagonist With Selective PPARγ–Modulating Activity

  2004cites this paper
• Renin-angiotensin system inhibition prevents type 2 diabetes mellitus. Part 2. Overview of physiological and biochemical mechanisms L'inhibition du système rénine angiotensine prévient le diabète de type 2. Partie 2. Analyse des mécanismes physiologiques et biochimiques

  2004cites this paper
• Blockade of the renin-angiotensin system decreases adipocyte size with improvement in insulin sensitivity.

  2004cites this paper
• Bradykinin B2 receptor gene C-58T polymorphism and insulin resistance. A study on obese patients.

  2004cites this paper
• Los inhibidores de la enzima de conversión tienen ventajas sobre los antagonistas de los receptores de angiotensina II

  2004cites this paper
• Isolation and characterization of a novel angiotensin I-converting enzyme inhibitory peptide derived from the edible mushroom Tricholoma giganteum

  2004cites this paper
• Blockade of the renin–angiotensin system decreases adipocyte size with improvement in insulin sensitivity

  2004cites this paper
• Renin-angiotensin system inhibition prevents type 2 diabetes mellitus. Part 2. Overview of physiological and biochemical mechanisms.

  2004cites this paper
• The kallikrein‐kinin system, angiotensin converting enzyme inhibitors and insulin sensitivity

  2004cites this paper
• Isolation and characterization of a novel angiotensin I-converting enzyme inhibitory peptide derived from the edible mushroom Tricholoma giganteum.

  2004cites this paper
• Putative roles of kinin receptors in the therapeutic effects of angiotensin 1-converting enzyme inhibitors in diabetes mellitus.

  2004cites this paper
• Neurohormonal antagonism in heart failure: what is the optimal strategy?

  2004cites this paper
• Effect of imidapril, an angiotensin-converting enzyme inhibitor, on fructose-induced insulin resistance in rats.

  2004cites this paper
• Antidiabetic mechanisms of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists: beyond the renin–angiotensin system

  2004cites this paper
• Effects of Dual Angiotensin-Converting Enzyme and Neutral Endopeptidase 24-11 Chronic Inhibition by Mixanpril on Insulin Sensitivity in Lean and Obese Zucker Rats

  2003cites this paper
• Enalapril Reduces the Incidence of Diabetes in Patients With Chronic Heart Failure: Insight From the Studies Of Left Ventricular Dysfunction (SOLVD)

  2003cites this paper
• Effects of ACE inhibition and AT1-receptor antagonism on endothelial function and insulin sensitivity in essential hypertensive patients

  2003cites this paper
• Nouveaux ligands PPAR qui ne provoquent pas de rétention de liquides, d'ýdème ou d'insuffisance cardiaque congestive

  2003cites this paper
• Effects of angiotensin II receptor antagonists on insulin resistance syndrome and leptin in sucrose-fed spontaneously hypertensive rats.

  2003cites this paper
• Enalapril reduces the incidence of diabetes in patients with chronic heart failure: insight from the Studies Of Left Ventricular Dysfunction (SOLVD).

  2003cites this paper
• Metabolic effects of angiotensin-converting enzyme inhibition: the role of bradykinin

  2002cites this paper
• Salt-Sensitive Rats High-Salt Diet Enhances Insulin Signaling and Induces Insulin Resistance in Dahl

  2002cites this paper
• Role of kallikrein-kininogen system in insulin-stimulated glucose transport after muscle contractions.

  2002cites this paper
• High-Salt Diet Enhances Insulin Signaling and Induces Insulin Resistance in Dahl Salt-Sensitive Rats

  2002cites this paper
• Hypertension and insulin disorders

  2002cites this paper
• Combined effect of ACE inhibitor and exercise training on insulin resistance in type 2 diabetic rats.

  2002cites this paper
• Combination therapy of exercise and angiotensin-converting enzyme inhibitor markedly improves insulin sensitivities in hypertensive patients with insulin resistance.

  2002cites this paper
• Effects of losartan in combination with or without exercise on insulin resistance in Otsuka Long-Evans Tokushima Fatty rats.

  2001cites this paper
• Changes in blood glucose and plasma insulin levels induced by bradykinin in anaesthetized rats

  2001cites this paper
• Nitric oxide does not participate in the metabolic effects of exogenous bradykinin in fructose-fed rats.

  2001cites this paper
• Role of the B2 Receptor of Bradykinin in Insulin Sensitivity

  2001cites this paper
• Angiotensin II type-1 receptor antagonist, CS-866, reduces blood pressure without affecting glucose/insulin metabolism in cholesterol-fed rabbits.

  2001cites this paper
• Differential effects of ACE-inhibition and angiotensin II antagonism on fibrinolysis and insulin sensitivity in hypertensive postmenopausal women.

  2001cites this paper
• Formulating clinical strategies for angiotensin antagonism: a review of preclinical and clinical studies.

  2001cites this paper
• Acute effect of the dual angiotensin‐converting enzyme and neutral endopeptidase 24‐11 inhibitor mixanpril on insulin sensitivity in obese Zucker rat

  2001cites this paper
• The role of ACE inhibition in heart failure

  2001cites this paper
• Antihypertensive Therapie bei Diabetes mellitus

  2001cites this paper
• Involvement of bradykinin in acute exercise-induced increase of glucose uptake and GLUT-4 translocation in skeletal muscle: studies in normal and diabetic humans and rats.

  2000cites this paper
• High- or low-salt diet from weaning to adulthood: effect on insulin sensitivity in Wistar rats.

  2000cites this paper
• Ramipril increases the protein level of skeletal muscle IRS-1 and alters protein tyrosine phosphatase activity in spontaneously hypertensive rats

  2000cites this paper
• Carvedilol does not alter the insulin sensitivity in patients with congestive heart failure

  2000cites this paper
• Bradykinin B2 receptor as a potential therapeutic target.

  2000cites this paper
• Defective nitric oxide synthesis: a link between metabolic insulin resistance, sympathetic overactivity and cardiovascular morbidity.

  2000cites this paper
• Distribution of c-fos mRNA in the brain following intracerebroventricular injection of nitric oxide (NO)-releasing compounds: possible role of NO in central cardiovascular regulation.

  2000cites this paper
• Effects of inhibition of the renin‐angiotensin system on the cardiovascular actions of insulin

  2000cites this paper
• Acute hemodynamic effects of insulin-sensitizing agents in isolated perfused rat hearts.

  2000cites this paper
• Bradykinin enhances membrane electrical activity of pancreatic beta cells in the presence of low glucose concentrations.

  2000cites this paper
• Cilnidipine Improves Insulin Sensitivity in the Otsuka Long-Evans Tokushima Fatty Rat, a Model of Spontaneous NIDDM

  1999cites this paper
• Insulin, nitric oxide and the sympathetic nervous system: at the crossroads of metabolic and cardiovascular regulation.

  1999cites this paper
• Insulin Sensitivity, Clearance and Release in Kininogen‐Deficient Rats

  1999cites this paper